DANA BARDEY: Open Payments
NPI 1922351774 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 80 payments from 14 companies in 2025. Trend: 2023 $1,898 · 2024 $2,165 · 2025 $1,765
Food & beverage: $1,765
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $404 |
| Abbott Laboratories | 2 | $305 |
| Edwards Lifesciences Corporation | 1 | $191 |
| Esperion Therapeutics, Inc. | 10 | $153 |
| E.R. Squibb & Sons, L.L.C. | 18 | $147 |
| Medtronic, Inc. | 1 | $120 |
| PFIZER INC. | 5 | $106 |
| Amgen Inc. | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
Products named: LEQVIO, ENSITE, KONECT RESILIA, NEXLETOL, AZURE XT DR MRI SURESCAN, CAMZYOS, ELIQUIS, REPATHA.
Industry payments across FL — which companies pay providers there.
